Josh D. Gregorio
30 works · 7,590 citations · h-index 16
Top works
- Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
- Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus
- Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus
- Plasmacytoid dendritic cells prime IL-10–producing T regulatory cells by inducible costimulator ligand
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
- Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
- Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions
- Inhibitors of TLR-9 Act on Multiple Cell Subsets in Mouse and Man In Vitro and Prevent Death In Vivo from Systemic Inflammation
- TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26
- Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37
- Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3+ T-Regulatory Cells
- Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity
- Generation of IL-23 Producing Dendritic Cells (DCs) by Airborne Fungi Regulates Fungal Pathogenicity via the Induction of TH-17 Responses
- A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes
- A minimal human immunostimulatory CpG motif that potently induces IFN‐γ and IFN‐α production
- Superior Activity of the Type C Class of ISS In Vitro and In Vivo Across Multiple Species
- Abstract 1559: TLR7/8 immune-stimulating antibody conjugates elicit robust myeloid activation leading to enhanced effector function and anti-tumor immunity in pre-clinical models
- 605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models
- Abstract 1559: TLR7/8 immune-stimulating antibody conjugates elicit robust myeloid activation leading to enhanced effector function and anti-tumor immunity in pre-clinical models
- Abstract 1580: LL-37-mediates tumor antigen-specific-T cell expansion and tumor regression